You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb304188 |
---|---|
Category | Small Molecules |
Description | Altiratinib is a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma. |
CAS Number | [1345847-93-9] |
MW | 510.4646 |
SMILES | FC1=C([H])C(=C(C([H])=C1N([H])C(C1(C(N([H])C2C([H])=C([H])C(=C([H])C=2[H])F)=O)C([H])([H])C1([H])[H])=O)F)OC1C([H])=C([H])N=C(C=1[H])N([H])C(C1([H])C([H])([H])C1([H])[H])=O |
Formula | C26H21F3N4O4 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Chemical structure of Altiratinib(DCC-2701)
Filter by Rating